• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病对老年男性心血管疾病风险及全因死亡率的影响:发病年龄、糖尿病病程以及既定和新型危险因素的作用

Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors.

作者信息

Wannamethee S Goya, Shaper A Gerald, Whincup Peter H, Lennon Lucy, Sattar Naveed

机构信息

Department of Primary Care and Population Health, University College London, Royal Free Campus, London NW3 2PF, England.

出版信息

Arch Intern Med. 2011 Mar 14;171(5):404-10. doi: 10.1001/archinternmed.2011.2.

DOI:10.1001/archinternmed.2011.2
PMID:21403036
Abstract

BACKGROUND

We have examined the influence of age at onset and duration on the impact of diabetes mellitus on cardiovascular disease risk and all cause-mortality among men aged 60 to 79 years.

METHODS

A prospective study of 4045 men aged 60 to 79 years followed up for a mean of 9 years, during which there were 372 major coronary heart disease (CHD) events (fatal and nonfatal myocardial infarction [MI]), 455 deaths from cardiovascular disease, and 1112 deaths from all causes. Men were classified as having (1) no history of MI and diabetes, (2) late-onset diabetes (diagnosed at ≥60 years or undiagnosed diabetes [fasting blood glucose level, >126.1 mg/dL]), (3) early-onset diabetes (diagnosed before age 60 years), or (4) prior MI.

RESULTS

Men who had both MI and diabetes were excluded. Both early and late onset of diabetes were associated with a significantly increased risk of major CHD events and all-cause mortality compared with nondiabetic men who had no CHD, even after adjustment for conventional risk factors and novel risk markers (levels of C-reactive protein and von Willebrand factor and renal dysfunction). Only men with early-onset diabetes (associated with a duration of 16.7 years) showed risk similar to those with previous MI and no diabetes. The adjusted relative risks (95% confidence intervals) for major CHD events were 1.00 (reference), 1.54 (1.07-2.21), 2.39 (1.41-4.05), and 2.51 (1.88-3.36) for groups 1 through 4, respectively.

CONCLUSION

Both early and late onset of diabetes are associated with increased risk of major CHD events and mortality, but only early onset of diabetes (associated with >10 years' duration) appears to be a CHD equivalent.

摘要

背景

我们研究了发病年龄和病程对60至79岁男性糖尿病对心血管疾病风险及全因死亡率影响的作用。

方法

对4045名60至79岁男性进行了一项前瞻性研究,平均随访9年,在此期间发生了372例主要冠心病(CHD)事件(致命和非致命性心肌梗死[MI])、455例心血管疾病死亡以及1112例全因死亡。男性被分为以下几类:(1)无MI和糖尿病病史;(2)迟发性糖尿病(≥60岁诊断或未诊断糖尿病[空腹血糖水平>126.1mg/dL]);(3)早发性糖尿病(60岁之前诊断);或(4)既往有MI。

结果

排除了既有MI又有糖尿病的男性。与无CHD的非糖尿病男性相比,糖尿病的早发和迟发均与主要CHD事件和全因死亡率的显著增加相关,即使在调整了传统危险因素和新型风险标志物(C反应蛋白和血管性血友病因子水平以及肾功能不全)之后也是如此。只有早发性糖尿病男性(病程为16.7年)显示出与既往有MI但无糖尿病的男性相似的风险。1至4组主要CHD事件的调整后相对风险(95%置信区间)分别为1.00(参照)、1.54(1.07 - 2.21)、2.39(1.41 - 4.05)和2.51(1.88 - 3.36)。

结论

糖尿病的早发和迟发均与主要CHD事件和死亡率增加相关,但只有糖尿病早发(病程>10年)似乎等同于CHD。

相似文献

1
Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors.糖尿病对老年男性心血管疾病风险及全因死亡率的影响:发病年龄、糖尿病病程以及既定和新型危险因素的作用
Arch Intern Med. 2011 Mar 14;171(5):404-10. doi: 10.1001/archinternmed.2011.2.
2
Diabetes and cardiovascular risk equivalency: do age at diagnosis and disease duration affect risk stratification?: comment on "impact of diabetes on cardiovascular disease risk and all-cause mortality in older men".糖尿病与心血管疾病风险等同性:诊断时的年龄和病程会影响风险分层吗?:对“糖尿病对老年男性心血管疾病风险和全因死亡率的影响”的评论
Arch Intern Med. 2011 Mar 14;171(5):410-1. doi: 10.1001/archinternmed.2010.524.
3
Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.需要降糖治疗的糖尿病患者与既往有心肌梗死的非糖尿病患者具有相同的心血管风险:一项对330万人的人群研究。
Circulation. 2008 Apr 15;117(15):1945-54. doi: 10.1161/CIRCULATIONAHA.107.720847. Epub 2008 Mar 31.
4
Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.2型糖尿病与冠心病风险:PROCAM研究10年随访结果
Eur J Cardiovasc Prev Rehabil. 2007 Apr;14(2):230-6. doi: 10.1097/HJR.0b013e3280142037.
5
Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial.糖尿病和既往心肌梗死对长期生存的影响:多重危险因素干预试验初筛人群25年死亡率随访
Arch Intern Med. 2004 Jul 12;164(13):1438-43. doi: 10.1001/archinte.164.13.1438.
6
A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.一项关于成年型糖尿病与女性冠心病和中风风险的前瞻性研究。
Arch Intern Med. 1991 Jun;151(6):1141-7.
7
A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease.一项关于同型半胱氨酸对2型糖尿病合并冠状动脉疾病患者预测价值的前瞻性队列研究。
Clin Chim Acta. 2006 Nov;373(1-2):70-6. doi: 10.1016/j.cca.2006.05.011. Epub 2006 May 16.
8
[Diabetes mellitus and myocardial infarct--new answers and questions].[糖尿病与心肌梗死——新的答案与问题]
Vutr Boles. 1999;31(4):29-34.
9
Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes.性别对心肌梗死合并 2 型糖尿病患者预后的影响。
J Intern Med. 2010 Jul;268(1):75-82. doi: 10.1111/j.1365-2796.2010.02215.x. Epub 2010 Jan 20.
10
The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease.糖尿病和心肌梗死在基线及随访期间对全因死亡率和冠心病死亡率的性别特异性影响。
J Am Coll Cardiol. 2005 May 3;45(9):1413-8. doi: 10.1016/j.jacc.2005.01.039.

引用本文的文献

1
Use of CT-derived non-cardiovascular calcification marker for predicting cardiovascular events among diabetic older adults: the multi-ethnic study of atherosclerosis.利用CT衍生的非心血管钙化标志物预测老年糖尿病患者的心血管事件:动脉粥样硬化多民族研究
Eur Radiol. 2025 Aug 9. doi: 10.1007/s00330-025-11778-9.
2
Glycemic Control in Patients with Diabetes on Peritoneal Dialysis: From Glucose Sparing Approach to Glucose Monitoring.腹膜透析糖尿病患者的血糖控制:从节约葡萄糖方法到血糖监测
Life (Basel). 2025 May 17;15(5):798. doi: 10.3390/life15050798.
3
Impact of Diabetes Duration on Major Adverse Cardiac Events in Patients with Non-Obstructive Coronary Artery Disease.
糖尿病病程对非阻塞性冠状动脉疾病患者主要不良心脏事件的影响
J Clin Med. 2025 Apr 18;14(8):2797. doi: 10.3390/jcm14082797.
4
Diabetes and the risk of cardiovascular events and all-cause mortality among older adults: an individual participant data analysis of five prospective studies.糖尿病与老年人心血管事件风险及全因死亡率:五项前瞻性研究的个体参与者数据分析
Eur J Clin Invest. 2025 Feb;55(2):e14340. doi: 10.1111/eci.14340. Epub 2024 Oct 28.
5
Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease-A Narrative Clinical Review.针对已确诊冠心病或有冠心病高风险的糖尿病患者的经典及新型降脂疗法——一项叙述性临床综述
Pharmaceuticals (Basel). 2024 Apr 29;17(5):568. doi: 10.3390/ph17050568.
6
Ensemble machine learning reveals key features for diabetes duration from electronic health records.集成机器学习从电子健康记录中揭示了糖尿病病程的关键特征。
PeerJ Comput Sci. 2024 Feb 26;10:e1896. doi: 10.7717/peerj-cs.1896. eCollection 2024.
7
A cross-sectional study in type 2 diabetes patients reveals that elevated pulse wave velocity predicts asymptomatic peripheral arterial disease associated with age and diabetes duration.一项针对2型糖尿病患者的横断面研究表明,脉搏波速度升高预示着与年龄和糖尿病病程相关的无症状外周动脉疾病。
Int J Cardiol Heart Vasc. 2023 Nov 26;49:101308. doi: 10.1016/j.ijcha.2023.101308. eCollection 2023 Dec.
8
The Impact of Statin Therapy on Cardiovascular Outcomes in Patients With Diabetes: A Systematic Review.他汀类药物治疗对糖尿病患者心血管结局的影响:一项系统评价。
Cureus. 2023 Oct 18;15(10):e47294. doi: 10.7759/cureus.47294. eCollection 2023 Oct.
9
Irisin suppresses pancreatic β cell pyroptosis in T2DM by inhibiting the NLRP3-GSDMD pathway and activating the Nrf2-TrX/TXNIP signaling axis.鸢尾素通过抑制NLRP3-GSDMD途径和激活Nrf2-TrX/TXNIP信号轴来抑制2型糖尿病中胰腺β细胞的焦亡。
Diabetol Metab Syndr. 2023 Nov 22;15(1):239. doi: 10.1186/s13098-023-01216-5.
10
Development and Validation of the American Heart Association's PREVENT Equations.美国心脏协会 PREVENT 方程的制定与验证。
Circulation. 2024 Feb 6;149(6):430-449. doi: 10.1161/CIRCULATIONAHA.123.067626. Epub 2023 Nov 10.